The presence of moderate-to-severe steatosis in nonobese MASLD may be associated with the effects of PLA2R1 rs35771982, whereas rs3749117 mutations may have pronounced effects on moderate-to-severe steatosis in obese MASLD patients. This evidence concerns the gene PLA2R1 and steatosis.